H pylori antibiotic resistance: prevalence, importance, and advances in testing.
作者信息
Mégraud F
机构信息
Laboratoire de Bactériologie, Hôpital Pellegrin, Place Amélie Raba-Léon, 33076 Bordeaux Cedex, France.
出版信息
Gut. 2004 Sep;53(9):1374-84. doi: 10.1136/gut.2003.022111.
Abstract
摘要
相似文献
1
H pylori antibiotic resistance: prevalence, importance, and advances in testing.
Gut. 2004 Sep;53(9):1374-84. doi: 10.1136/gut.2003.022111.
2
Efficacy of real-time PCR-based detection of Helicobacter pylori infection and genotypic resistance-guided quadruple therapy as the first-line treatment for functional dyspepsia with Helicobacter pylori infection.
Eur J Gastroenterol Hepatol. 2015 Mar;27(3):221-5. doi: 10.1097/MEG.0000000000000186.
3
High prevalence of primary antibiotic resistance in Helicobacter pylori isolates in Italy.
J Gastrointestin Liver Dis. 2012 Dec;21(4):363-5.
4
Comparison of FISH, RFLP and agar dilution methods for testing clarithromycin resistance of Helicobacter pylori.
Turk J Gastroenterol. 2014 Dec;25 Suppl 1:75-80. doi: 10.5152/tjg.2014.4688.
5
Detection and clarithromycin susceptibility testing of Helicobacter pylori in stool specimens by real-time PCR: how to get accurate test results.
J Clin Microbiol. 2007 Aug;45(8):2756; author reply 2756-7. doi: 10.1128/JCM.00846-07.
6
Antibiotic resistance of Helicobacter pylori in Mazandaran, North of Iran.
Helicobacter. 2010 Dec;15(6):505-9. doi: 10.1111/j.1523-5378.2010.00795.x.
7
[Antibiotic resistance of Helicobacter pylori].
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2007 Jun;32(3):447-50.
8
Impact of clarithromycin resistance on eradication of Helicobacter pylori in infected adults.
Antimicrob Agents Chemother. 2005 Apr;49(4):1600-3. doi: 10.1128/AAC.49.4.1600-1603.2005.
9
High Helicobacter pylori resistance to metronidazole but zero or low resistance to clarithromycin, levofloxacin, and other antibiotics in Malaysia.
Helicobacter. 2011 Jun;16(3):241-5. doi: 10.1111/j.1523-5378.2011.00841.x.
10
Primary clarithromycin resistance to Helicobacter pylori and therapy failure in children: the experience in West Virginia.
J Pediatr Gastroenterol Nutr. 2006 Mar;42(3):327-8. doi: 10.1097/01.mpg.0000214157.52822.40.
引用本文的文献
1
Effectiveness of first line therapy for Helicobacter pylori infection in children and adolescents: A multicenter study in the United Arab Emirates.
PLoS One. 2025 Aug 28;20(8):e0318315. doi: 10.1371/journal.pone.0318315. eCollection 2025.
2
Detection of Clarithromycin Resistance in Helicobacter pylori Using the AllplexTM H. pylori & ClariR Assay and the Ezplex® HP-CLA Real-Time PCR Kit.
Korean J Helicobacter Up Gastrointest Res. 2025 Mar;25(1):42-47. doi: 10.7704/kjhugr.2024.0070. Epub 2025 Mar 7.
3
[Evidence-based Therapy: A Rational Approach to Eradication].
Korean J Helicobacter Up Gastrointest Res. 2023 Jun;23(2):81-83. doi: 10.7704/kjhugr.2023.0027. Epub 2023 Jun 12.
4
Prevalence and Variability of Clarithromycin Resistance Mutations in Pediatric Patients in Poland: A Genotypic Analysis Using the Bosphore Genotyping Kit.
Antibiotics (Basel). 2025 Mar 31;14(4):352. doi: 10.3390/antibiotics14040352.
5
A Comprehensive Overview of Antibacterial Agents for Combating Multidrug-Resistant Bacteria: The Current Landscape, Development, Future Opportunities, and Challenges.
Antibiotics (Basel). 2025 Feb 21;14(3):221. doi: 10.3390/antibiotics14030221.
6
Declining eradication rates of with standard triple therapy in Addis Ababa, Ethiopia.
World J Gastroenterol. 2025 Feb 21;31(7):97401. doi: 10.3748/wjg.v31.i7.97401.
7
resistance in Hainan Province, China: investigating phenotypes and genotypes through whole-genome sequencing.
Front Cell Infect Microbiol. 2024 Dec 17;14:1505166. doi: 10.3389/fcimb.2024.1505166. eCollection 2024.
8
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for infection between 2013 and 2021: results from the European registry on management (Hp-EuReg).
Gut. 2024 Dec 10;74(1):15-25. doi: 10.1136/gutjnl-2024-332804.
9
PCR-based RFLP and ERIC-PCR patterns of Helicobacter pylori strains linked to multidrug resistance in Egypt.
Sci Rep. 2024 Sep 27;14(1):22273. doi: 10.1038/s41598-024-72289-z.
10
Interrelation: gastric microbiota - acid-dependent diseases, and more….
Med Pharm Rep. 2021 Nov;94(Suppl No 3):S12-S18. doi: 10.15386/mpr-2510. Epub 2021 Nov 29.
本文引用的文献
1
Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori.
Antimicrob Agents Chemother. 2003 Dec;47(12):3942-4. doi: 10.1128/AAC.47.12.3942-3944.2003.
2
Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies.
Helicobacter. 2003 Dec;8(6):626-42. doi: 10.1111/j.1523-5378.2003.00179.x.
3
Metronidazole-resistant Helicobacter pylori is more prevalent in patients with nonulcer dyspepsia than in peptic ulcer patients in a multiethnic Asian population.
J Clin Microbiol. 2003 Nov;41(11):5011-4. doi: 10.1128/JCM.41.11.5011-5014.2003.
4
Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998-2002.
Dig Liver Dis. 2003 Aug;35(8):541-5. doi: 10.1016/s1590-8658(03)00265-2.
5
Role of antibiotic sensitivity testing before first-line Helicobacter pylori eradication treatments.
Aliment Pharmacol Ther. 2003 Oct 15;18(8):821-7. doi: 10.1046/j.1365-2036.2003.01757.x.
6
Second-line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies.
Aliment Pharmacol Ther. 2003 Oct 15;18(8):791-7. doi: 10.1046/j.1365-2036.2003.01759.x.
7
Fast and accurate quantitative detection of Helicobacter pylori and identification of clarithromycin resistance mutations in H. pylori isolates from gastric biopsy specimens by real-time PCR.
J Clin Microbiol. 2003 Oct;41(10):4573-7. doi: 10.1128/JCM.41.10.4573-4577.2003.
8
The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections.
Ann Intern Med. 2003 Sep 16;139(6):463-9. doi: 10.7326/0003-4819-139-6-200309160-00008.
9
Effects of 16S rRNA gene mutations on tetracycline resistance in Helicobacter pylori.
Antimicrob Agents Chemother. 2003 Sep;47(9):2984-6. doi: 10.1128/AAC.47.9.2984-2986.2003.
10
Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates.
BMC Gastroenterol. 2003 Aug 11;3:20. doi: 10.1186/1471-230X-3-20.
Zotero 插件